lansoprazole has been researched along with Immunologic Deficiency Syndromes in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajer, A | 1 |
| Bednarska, M | 1 |
| Cacciò, SM | 1 |
| Wolska-Kuśnierz, B | 1 |
| Heropolitanska-Pliszka, E | 1 |
| Bernatowska, E | 1 |
| Wielopolska, M | 1 |
| Paziewska, A | 1 |
| Welc-faleciak, R | 1 |
| Siński, E | 1 |
1 other study available for lansoprazole and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Genotyping of Cryptosporidium isolates from human clinical cases in Poland.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Animals; Child; Cryptosporidiosis; Cryptosporidium; | 2008 |